CClinicalTrials.gg
CompletedNCT02972814T-POCTUpdated Apr 21, 2021

Time Gain in the Diagnosis Myocardial Infarction by Troponin Point of Care Testing in the Emergency Room

An observational study in Non STEMI, Angina Pectoris and Angina, Stable, sponsored by Ziekenhuis Oost-Limburg. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-04-21.

Sponsored by Ziekenhuis Oost-Limburg · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
66
Ages
18 Years and older
Sex
All
01

Study summary

The investigators prospectively want to compare 3 clinical tests for measuring blood troponin levels in patients presenting to the emergency room with thoracic pain probably related to a myocardial infarction with regard to the time necessary to obtain the test results.

The tests are one laboratory based test and two point of care tests.

Read the detailed description

Thoracic pain can be caused by a myocardial infarction. The diagnosis of a myocardial infarction can be made by an ECG (ST-elevation myocardial infarction, STEMI). However, some myocardial infarctions can also occur without ST-elevations on the ECG (non-ST-elevation myocardial infarction, non-STEMI). In the latter case, a quick acquisition of blood troponin levels is necessary to coin the diagnosis and initiate treatment. Therefore, the investigators prospectively want to compare 3 clinical tests for measuring blood troponin levels in patients presenting to the emergency room with thoracic pain probably related to a non-STEMI with regard to the time necessary to obtain the test results.

The 3 tests are:

  1. A laboratory based test: Roche Cobas E 602
  2. A point of care test: Radiometer AQT 90 Flex
  3. A point of care test: Philips Minicare I-20

The measured timeframe is the time between venipuncture to the point the test results are known.

02

Conditions studied

  • Non STEMI
  • Angina Pectoris
  • Angina, Stable
  • Angina, Unstable
  • Angina, Prinzmetal's

Keywords

  • Troponin
  • Point of care test
  • myocardial infarction
03

In context

Myocardial Infarction

2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.

This study's enrollment of 66 is below the median of 500 across 983 observational studies indexed under Myocardial Infarction.

Browse Myocardial Infarction studies →

Lead sponsor

Ziekenhuis Oost-Limburg is the lead sponsor of 66 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients presenting to the emergency room with thoracic pain due to a non-STEMI

Inclusion criteria

  • Thoracic pain

Exclusion criteria

Exclusion Criteria:

  • Unable to give informed consent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
66 participants (actual)
Patient registry
No

Groups and cohorts

  • Thoracic pain

    Patients presenting to the emergency room with thoracic pain probably due to a non-STEMI

    Device: Laboratory based troponin test · Device: Point of care based troponin test 1 · Device: Point of care based troponin test 2

Interventions

  • DeviceLaboratory based troponin test

    acquisition of blood troponin level by Roche Cobas E 603

  • DevicePoint of care based troponin test 1

    acquisition of blood troponin level by Radiometer EQT 90 Flex

  • DevicePoint of care based troponin test 2

    acquisition of blood troponin level by Philips Minicare I-20

06

What researchers measure

Primary outcomes

  1. time delay until troponin test results are known

    Time frame: From the time of venipuncture to the time the troponin test results are known: up to 6 hours

07

Study locations

1 site
  • Ziekenhuis Oost-Limburg
    Genk, Limburg 3600, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02972814
Lead sponsor
Ziekenhuis Oost-Limburg
Responsible party
Pascal Vanelderen (Prof. dr., Ziekenhuis Oost-Limburg) — Principal investigator
First posted
Nov 23, 2016
Start date
Feb 1, 2017
Primary completion
Jun 30, 2020
Completion
Jun 30, 2020
Last update
Apr 21, 2021

Study contacts

Pascal Vanelderen, MD, PhDD
principal investigator · Member of Staff

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion